000 | 01707 a2200445 4500 | ||
---|---|---|---|
005 | 20250514044149.0 | ||
264 | 0 | _c20021119 | |
008 | 200211s 0 0 eng d | ||
022 | _a0006-2960 | ||
024 | 7 |
_a10.1021/bi020270p _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYu, Deshan | |
245 | 0 | 0 |
_aPolycyclic aromatic hydrocarbon o-quinones inhibit the activity of the catalytic fragment of protein kinase C. _h[electronic resource] |
260 |
_bBiochemistry _cOct 2002 |
||
300 |
_a11888-94 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_a9,10-Dimethyl-1,2-benzanthracene _xpharmacology |
650 | 0 | 4 |
_aBenzopyrenes _xpharmacology |
650 | 0 | 4 | _aBiotransformation |
650 | 0 | 4 |
_aCatalytic Domain _xdrug effects |
650 | 0 | 4 |
_aDihydroxydihydrobenzopyrenes _xpharmacology |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemistry |
650 | 0 | 4 |
_aHoloenzymes _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
650 | 0 | 4 |
_aNaphthols _xpharmacology |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 |
_aPeptide Fragments _xantagonists & inhibitors |
650 | 0 | 4 |
_aPolycyclic Aromatic Hydrocarbons _xchemistry |
650 | 0 | 4 |
_aProtein Kinase C _xantagonists & inhibitors |
650 | 0 | 4 |
_aQuinones _xchemistry |
650 | 0 | 4 |
_aSubcellular Fractions _xdrug effects |
650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
700 | 1 | _aKazanietz, Marcelo G | |
700 | 1 | _aHarvey, Ronald G | |
700 | 1 | _aPenning, Trevor M | |
773 | 0 |
_tBiochemistry _gvol. 41 _gno. 39 _gp. 11888-94 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi020270p _zAvailable from publisher's website |
999 |
_c12129140 _d12129140 |